What is it about?
We examined mutations that E. coli bacteria picked up during antibiotic treatment in patients. We found that some mutations led to increased production of antibiotic tolerant persister subpopulations. These strains also showed decreased susceptibility to antibiotics in our murine model of infection.
Featured Image
Photo by Hush Naidoo Jade Photography on Unsplash
Why is it important?
This paper provides important evidence that persister cell formation is contributing to antibiotic treatment failure in the clinic.
Perspectives
We need to develop a more thorough understanding of why antibiotic fail in the clinic. Resistance only explains a small proportion of patient deaths. The more thorough an understanding we develop, the better our capability will be to identify problematic isolates, choose more appropriate therapy and develop new treatments to improve patient outcomes.
Brian Conlon
University of North Carolina at Chapel Hill
Read the Original
This page is a summary of: In-patient evolution of a high-persister
Escherichia coli
strain with reduced in vivo antibiotic susceptibility, Proceedings of the National Academy of Sciences, January 2024, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2314514121.
You can read the full text:
Contributors
The following have contributed to this page
